Great West Life Assurance CO Cara Therapeutics, Inc. Transaction History

Great West Life Assurance CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$4.89 - $12.27 $4,498 - $11,288	-920 Reduced 1.5%	60,306 $295,000
Q4 2022 Feb 10, 2023	BUY	$8.88 - $12.77 $26,657 - $38,335	3,002 Added 5.16%	61,226 $658,000
Q3 2022 Nov 01, 2022	BUY	$8.24 - $12.56 $145,773 - $222,198	17,691 Added 43.65%	58,224 $545,000
Q2 2022 Aug 12, 2022	BUY	$7.45 - $13.84 $301,970 - $560,976	40,533 New	40,533 $369,000
Q2 2022 Aug 09, 2022	SELL	$7.45 - $13.84 $268,632 - $499,042	-36,058 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$12.38 - $29.19 $402,510 - $949,054	32,513 Added 917.15%	36,058 $514,000
Q3 2020 Nov 17, 2020	BUY	$12.34 - $17.92 $43,745 - $63,526	3,545 New	3,545 $45,000
Q3 2020 Nov 13, 2020	SELL	$12.34 - $17.92 $43,745 - $63,526	-3,545 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$16.11 - $25.98 $57,109 - $92,099	3,545 New	3,545 $57,000
Q3 2019 Oct 25, 2019	SELL	$18.28 - $26.91 $45,572 - $67,086	-2,493 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$17.68 - $21.57 $65,964 - $80,477	-3,731 Reduced 59.95%	2,493 $0
Q1 2019 May 08, 2019	BUY	$14.41 - $19.64 $50,780 - $69,211	3,524 Added 130.52%	6,224 $122,000
Q3 2017 Nov 09, 2017	BUY	$12.6 - $16.34 $34,020 - $44,118	2,700	2,700 $36,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.